You are here

Eli Lilly

4 Reasons to Be Wary of This Animal Health IPO

Motley Fool

Tue, 10/9/18 - 04:58 pm

Lilly makes waves with next-generation diabetes drug, but GLP-1 rivals needn't panic: analysts

Fierce Pharma

Mon, 10/8/18 - 11:03 pm

Lilly’s breast cancer drug Verzenio approved in EU

Pharmaforum

Sat, 10/6/18 - 12:45 pm

Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?

Fierce Pharma

Fri, 10/5/18 - 08:51 pm

Boehringer Ingelheim

Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results

Endpoints

Thu, 10/4/18 - 11:58 am

Eli Lilly's diabetes treatment meets main goal in two late-stage studies

Reuters

Tue, 10/2/18 - 10:54 pm

Ultra Rapid Lispro

type 1 diabetes

type 2 diabetes

Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags

Marketwatch

Fri, 09/28/18 - 12:32 pm

Teva Pharmaceutical

Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of its ED blockbuster

Fierce Pharma

Fri, 09/28/18 - 11:58 am

Teva Pharmaceutical

erectile dysfunction

Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP

Fierce Pharma

Thu, 09/27/18 - 11:25 pm

Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront

BioSpace

Thu, 09/27/18 - 11:53 am

type 2 diabetes

Elanco’s $1.7 billion IPO looks too pricey, and here’s why

Marketwatch

Thu, 09/20/18 - 09:49 am

Eli Lilly got Indianapolis tax break despite pending appeals

AP

Mon, 09/10/18 - 12:14 am

Eli Lilly's New PET Scan Offers Another Tool for Studying Alzheimer's

BioSpace

Fri, 09/7/18 - 11:02 am

Avid Radiopharmaceuticals

Alzheimer's disease

Tanezumab's Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments

Forbes

Thu, 09/6/18 - 09:44 am

pain management

clinical trials

Boost for "made in China" medicine as Chi-Med wins key approval

Yahoo/Reuters

Wed, 09/5/18 - 09:08 am

colorectal cancer

Trulicity’s turn to show a cardiovascular benefit

EP Vantage

Tue, 09/4/18 - 05:04 pm

Adocia and Lilly’s legal tussle intensifies as diabetes deal goes wrong

Pharmaforum

Mon, 09/3/18 - 12:11 pm

Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates

Yahoo/Benzinga

Sat, 09/1/18 - 03:38 pm

Teva Pharmaceutical

Adamis Pharmaceuticals

Did HHS chief Alex Azar work with ex-employer Lilly on drug rebate plans? A watchdog wants to know

Fierce Pharma

Fri, 08/31/18 - 11:46 pm

Conor Daly's Lilly sponsorship decals removed because of father's use of racial slur in 1980s

Indianapolis Star, IN

Mon, 08/27/18 - 11:35 am

celebrity endorsements

Pages